ARG55397

anti-MART1 / Melan A antibody

anti-MART1 / Melan A antibody for Flow cytometry,Western blot and Human

Cancer antibody; Controls and Markers antibody

概述

产品描述 Rabbit Polyclonal antibody recognizes MART1 / Melan A
反应物种 Hu
应用 FACS, WB
宿主 Rabbit
克隆 Polyclonal
同位型 IgG
靶点名称 MART1 / Melan A
抗原物种 Human
抗原 KLH-conjugated synthetic peptide corresponding to aa. 34-60 (Center) of Human MART1 / Melan A.
偶联标记 Un-conjugated
別名 MART-1; MART1; Protein Melan-A; Antigen SK29-AA; Antigen LB39-AA; Melanoma antigen recognized by T-cells 1

应用说明

应用建议
应用 推荐稀释比
FACS1:10 - 1:50
WB1:1000
应用说明 * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
阳性对照 HL-60

属性

形式 Liquid
纯化 Purification with Protein A and immunogen peptide.
缓冲液 PBS and 0.09% (W/V) Sodium azide
抗菌剂 0.09% (W/V) Sodium azide
存放说明 For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
注意事项 For laboratory research only, not for drug, diagnostic or other use.

生物信息

数据库连接

GeneID: 2315 Human MLANA

Swiss-port # Q16655 Human Melanoma antigen recognized by T-cells 1

基因名称 MLANA
全名 melan-A
生物功能 Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes. [UniProt]
研究领域 Cancer antibody; Controls and Markers antibody
预测分子量 13 kDa
翻译后修饰 Acylated.

检测图片 (2) Click the Picture to Zoom In

  • ARG55397 anti-MART1 / Melan A antibody WB image

    Western blot: 35 µg of HL-60 cell lysate stained with ARG55397 anti-MART1 / Melan A antibody.

  • ARG55397 anti-MART1 / Melan A antibody FACS image

    Flow Cytometry: HL-60 cells stained with ARG55397 anti-MART1 / Melan A antibody (right histogram) or without primary antibody control (left histogram), followed by incubation with FITC labelled secondary antibody.